BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 7769902)

  • 1. Individualised low-dose alglucerase therapy for type 1 Gaucher's disease.
    Hollak CE; Aerts JM; Goudsmit R; Phoa SS; Ek M; van Weely S; von dem Borne AE; van Oers MH
    Lancet; 1995 Jun; 345(8963):1474-8. PubMed ID: 7769902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A less costly regimen of alglucerase to treat Gaucher's disease.
    Figueroa ML; Rosenbloom BE; Kay AC; Garver P; Thurston DW; Koziol JA; Gelbart T; Beutler E
    N Engl J Med; 1992 Dec; 327(23):1632-6. PubMed ID: 1435900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alglucerase. A review of its therapeutic use in Gaucher's disease.
    Whittington R; Goa KL
    Drugs; 1992 Jul; 44(1):72-93. PubMed ID: 1379912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replacement therapy with imiglucerase for type 1 Gaucher's disease.
    Zimran A; Elstein D; Levy-Lahad E; Zevin S; Hadas-Halpern I; Bar-Ziv Y; Foldes J; Schwartz AJ; Abrahamov A
    Lancet; 1995 Jun; 345(8963):1479-80. PubMed ID: 7769903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose enzyme replacement therapy for Gaucher's disease: effects of age, sex, genotype, and clinical features on response to treatment.
    Zimran A; Elstein D; Kannai R; Zevin S; Hadas-Halpern I; Levy-Lahad E; Cohen Y; Horowitz M; Abrahamov A
    Am J Med; 1994 Jul; 97(1):3-13. PubMed ID: 8030654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Alglucerase treatment of type I Gaucher's disease. Preliminary results in Spain. Spanish Group on Gaucher's Disease].
    Pérez-Calvo JI; Giraldo P; Giralt M
    Sangre (Barc); 1997 Jun; 42(3):189-94. PubMed ID: 9381260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alglucerase. A pharmacoeconomic appraisal of its use in the treatment of Gaucher's disease.
    Whittington R; Goa KL
    Pharmacoeconomics; 1995 Jan; 7(1):63-90. PubMed ID: 10155294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended interval between enzyme therapy infusions for adult patients with Gaucher's disease type 1.
    Pérez-Calvo J; Giraldo P; Pastores GM; Fernández-Galán M; Martín-Nuñez G; Pocoví M
    J Postgrad Med; 2003; 49(2):127-31. PubMed ID: 12867687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gaucher's disease: a review.
    Morales LE
    Ann Pharmacother; 1996 Apr; 30(4):381-8. PubMed ID: 8729893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme replacement therapy for Gaucher's disease.
    Beutler E
    Baillieres Clin Haematol; 1997 Dec; 10(4):751-63. PubMed ID: 9497862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzyme replacement treatment in type 1 and type 3 Gaucher's disease.
    Bembi B; Zanatta M; Carrozzi M; Baralle F; Gornati R; Berra B; Agosti E
    Lancet; 1994 Dec; 344(8938):1679-82. PubMed ID: 7996964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Enzyme replacement therapy: a new treatment concept in Gaucher disease].
    Beck M; Mengel E; Barone R
    Wien Klin Wochenschr; 1997 Feb; 109(3):81-5. PubMed ID: 9139464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Type I Gaucher's disease: clinical, evolutive and therapeutic features in 8 cases].
    Giraldo P; Pérez-Calvo J; Cortés T; Civeira F; Rubio-Félix D
    Sangre (Barc); 1994 Feb; 39(1):3-7. PubMed ID: 8197516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Uveitis masquerade syndrome in Gaucher disease. Causal treatment by alglucerase substitution therapy].
    Dann K; Althaus C; Kersten A; vom Dahl S; Sundmacher R
    Klin Monbl Augenheilkd; 1998 Dec; 213(6):358-61. PubMed ID: 10048015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eliglustat compared with imiglucerase in patients with Gaucher's disease type 1 stabilised on enzyme replacement therapy: a phase 3, randomised, open-label, non-inferiority trial.
    Cox TM; Drelichman G; Cravo R; Balwani M; Burrow TA; Martins AM; Lukina E; Rosenbloom B; Ross L; Angell J; Puga AC
    Lancet; 2015 Jun; 385(9985):2355-62. PubMed ID: 25819691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic targets in Gaucher's disease].
    Giraldo P; Roca M
    Med Clin (Barc); 2011 Sep; 137 Suppl 1():46-9. PubMed ID: 22230126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis and therapy of Gaucher disease].
    Ehlen C; Heintges T; Niederau C
    Med Klin (Munich); 1995 May; 90(5):284-90. PubMed ID: 7791695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzyme replacement therapy for Gaucher's disease: the early Canadian experience.
    MacKenzie JJ; Amato D; Clarke JT
    CMAJ; 1998 Nov; 159(10):1273-8. PubMed ID: 9861225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocerebrosidase for treatment of Gaucher's disease: first German long-term results.
    Niederau C; Holderer A; Heintges T; Strohmeyer G
    J Hepatol; 1994 Oct; 21(4):610-7. PubMed ID: 7814809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose versus high-frequency regimens in Gaucher's disease.
    Hollak CE; Goudsmit R; van Oers MH
    Lancet; 1996 Feb; 347(8998):406-7. PubMed ID: 8598739
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.